Current NDC auxiliary source row compounder:968

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 61141-4536
Product Ndc: 61141-4536
Product Ndc Digits: 611414536
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Proparacaine HCl Repak 0.5%, 0.4ml in syringe
Proprietary Name Suffix: [empty]
Nonproprietary Name: Proparacaine HCl Repak
Dosage Form Name: SOLUTION/ DROPS
Route Name: OPHTHALMIC
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Medi-Fare Drug
Establishment Name: Medi-Fare Drug
Establishment Fei: [empty]
Substance Name: PROPARACAINE HYDROCHLORIDE
Active Ingredients Info: 5 mg/1 mL
History Active Ingredients Raw: PROPARACAINE HYDROCHLORIDE
History Active Ingredients Info Raw: 5 mg/1 mL
History Dosage Raw: SOLUTION/ DROPS
Dea Schedule: [empty]
Package Ndc Raw: 61141-4536-4
Package Ndc: 61141-4536-4
Package Ndc Digits: 6114145364
Package Ndc11: 61141453604
Package Description: .4 mL in 1 SYRINGE, PLASTIC (61141-4536-4)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:968
Source Row Number: 968
Source Row Hash: ef7df9055767ed567f6567ac0892cac4a1f27da639daeb3498f034458f505317
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "OPHTHALMIC",
    "PRODUCTNDC": "61141-4536",
    "DEASCHEDULE": "",
    "LABELERNAME": "Medi-Fare Drug",
    "SUBSTANCENAME": "PROPARACAINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "SOLUTION/ DROPS",
    "NDCPACKAGECODE": "61141-4536-4",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Proparacaine HCl Repak 0.5%, 0.4ml in syringe",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Proparacaine HCl Repak",
    "PACKAGEDESCRIPTION": ".4 mL in 1 SYRINGE, PLASTIC (61141-4536-4) ",
    "ACTIVEINGREDIENTSINFO": "5 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:968
Source Row Number: 968
Status Scope: package
Lookup Ndc: 61141-4536-4
Lookup Ndc Digits: 6114145364
Product Ndc: 61141-4536
Product Ndc Digits: 611414536
Package Ndc: 61141-4536-4
Package Ndc Digits: 6114145364
Package Ndc11: 61141453604
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: ef7df9055767ed567f6567ac0892cac4a1f27da639daeb3498f034458f505317
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51